Form 4: MYGN CFO Acquires Shares, Tax Withholding Disclosures

Myriad Genetics CFO Benjamin Richard Wheeler reported the acquisition of 206,186 restricted stock units and subsequent disposals for tax withholding.

Summary

• Chief Financial Officer Benjamin Richard Wheeler acquired 206,186 shares of Common Stock through time-based restricted stock units (RSUs) on March 12, 2026.
• These RSUs were granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan and vest in three equal annual installments beginning on the first anniversary of the grant date.
• Shares were withheld by Myriad Genetics to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units.
• Disposals for tax withholding occurred on March 13, 2026 (586 shares), March 14, 2026 (1,097 shares), and March 15, 2026 (877 shares and 2,192 shares).
• The number of shares withheld was determined based on the closing price of Myriad Genetics' Common Stock on March 13, 2026, which was $4.66 per share.
• Following these reported transactions, Benjamin Richard Wheeler beneficially owns 299,058 shares of Common Stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as the CFO's acquisition of a significant number of restricted stock units indicates continued alignment with shareholder interests, despite the routine tax-related disposals.

Positives

• The acquisition of 206,186 restricted stock units by the Chief Financial Officer aligns management's interests with those of shareholders, indicating continued commitment to the company's performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly acquisitions of equity through compensation plans, can signal management's confidence in the company's future performance, aligning executive interests with those of shareholders. The disposals for tax withholding are a standard part of executive compensation and do not typically reflect a change in sentiment.

Stakeholder Impact

• Shareholders: The acquisition of equity by the CFO enhances alignment between management and shareholder interests.
• Employees: The filing reflects standard executive compensation practices, which can influence overall employee compensation structures and morale.

Next Steps

• The acquired restricted stock units will vest in three equal annual installments beginning on the first anniversary of the grant date (March 12, 2027).

Key Dates

Recommendation

This Form 4 filing details routine executive compensation and tax-related stock disposals, which do not provide new fundamental information to warrant a change in investment recommendation. The acquisition of restricted stock units by the CFO is a positive for alignment but is part of a pre-existing compensation plan.

Keywords

Myriad Genetics, MYGN, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation, CFO, Equity Incentive Plan